Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
6.09
-0.21 (-3.33%)
At close: Sep 28, 2026, 4:00 PM EDT
6.20
+0.11 (1.81%)
Pre-market: Sep 29, 2026, 8:16 AM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $267.3 million as of September 28, 2026. Its market cap has decreased by -82.57% in one year.
Market Cap
267.30M
Enterprise Value
255.40M
1-Year Change
-82.57%
Ranking
Category
Stock Price
$6.09
ChartMarket Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $267.30M, an increase of 21.80%. That is a compound annual growth rate of 13.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 267.30M | -79.75% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| STAAR Surgical Company | 1.05B |
| AngioDynamics | 642.31M |
| Embecta | 335.99M |
| Sanara MedTech | 322.50M |
| OraSure Technologies | 272.43M |
| Utah Medical Products | 237.16M |
| Pro-Dex | 229.42M |
| Jin Medical International | 152.94M |